Watton-at-Stone, United Kingdom

Mark Peter Ridgill



Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 212(Granted Patents)


Location History:

  • Harlow, GB (1995)
  • Watton-At-Stone, GB (1996 - 2009)
  • Dover, GB (2011 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Mark Peter Ridgill: Innovator in Alzheimer's Disease Treatment

Introduction: Mark Peter Ridgill, based in Watton-at-Stone, GB, is a notable inventor with an impressive portfolio of 19 patents. His work primarily focuses on developing compounds that target diseases such as Alzheimer's and dementia, potentially transforming treatment approaches in these critical areas.

Latest Patents: Ridgill's latest patents include key developments in the treatment of Alzheimer's disease with compounds that modulate gamma-secretase. His research on piperidines and related compounds demonstrates significant promise in managing the condition, offering new avenues for therapeutic intervention.

Career Highlights: Throughout his career, Mark Ridgill has made substantial contributions to pharmaceutical innovation, particularly during his time at Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. His research efforts reflect a strong commitment to addressing the needs associated with neurodegenerative diseases.

Collaborations: Collaboration is a cornerstone of Ridgill's work, as he has partnered with distinguished colleagues such as Janusz Jozef Kulagowski and Andrew Madin. These collaborations have enhanced the depth and impact of his research, facilitating advancements in the treatment of Alzheimer's disease and related conditions.

Conclusion: Mark Peter Ridgill's dedication to innovation in medicine is evident through his numerous patents and collaborative efforts. His pioneering work in developing therapies for Alzheimer's disease positions him as a significant figure in the ongoing pursuit of effective treatments for cognitive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…